DOCSLIB.ORG

Table 2 PDF File

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table 2 PDF File Table 2. List of genes clustered by k-mean clustering Normalized Average Expression Level k-mean Clone name Putative Identification ACC# MEF ES TS3 TS6 Cluster #1 H3014B04 Unknown -0.451 -0.619 0.632 -0.113 H3015G08 Mouse facilitated glucose transport protein M23384.1 -0.756 -0.216 0.601 -0.14 H3016G11 Mouse connexin 31.1 M91236.1 -0.507 -0.177 0.537 -0.649 H3017B04 Human ATPase, Class I, type 8B, member 2 (ATP8B2) XM_036933.3 -0.346 -0.378 0.533 -0.672 H3021D02 Mouse melanoma-associated antigen (MAAT1) BC002293.1 -0.116 -0.538 0.689 -0.469 H3022A09 Mouse clone MGC:7200 BC009098.1 -0.721 -0.012 0.602 -0.339 H3023A08 Human LOC122403 AJ318887.1 -0.38 -0.344 0.734 -0.443 H3023G02 Mouse proteolipid protein 2 (Plp2) NM_019755.1 -0.641 -0.489 0.585 -0.081 H3035G07 Human clone IMAGE:3848662 XM_036299.2 -0.542 -0.137 0.556 -0.613 H3042F12 Mouse serine protease inhibitor 4 (Spi4) NM_009255.1 -0.474 -0.419 0.181 -0.752 H3054A11 Human thyroid hormone receptor interactor 12 (TRIP12) NM_004238.1 -0.52 -0.587 0.606 -0.127 H3060F01 Mouse X-linked lymphocyte-regulated 3b (Xlr3b) NM_011727.1 -0.382 -0.743 0.359 -0.414 H3064E06 Mouse clone IMAGE:4020609 BC020328.1 -0.369 -0.239 0.623 -0.645 H3065F10 Mouse hypothetical protein expressed in thymocytes AJ237585.1 -0.662 -0.038 0.572 -0.481 H3066C11 Mouse partial mRNA for TAFII140 AJ292189.1 -0.303 -0.541 0.539 -0.568 H3067A10 Unknown -0.671 -0.402 0.58 -0.223 H3067B11 Unknown -0.4 -0.485 0.545 -0.552 H3067C11 Unknown -0.716 -0.129 0.596 -0.337 H3067G02 Human HSPC (CD34+ hematopoietic stem/progenitor cells)-296 protein AF161414.1 -0.301 -0.512 0.738 -0.316 H3072A01 Mouse protein tyrosine phosphatase 21 with homology to cytoskeltal protein 4.1 NM_011877.1 -0.44 -0.115 0.535 -0.711 H3084F06 Unknown AK007274.1 -0.492 -0.478 0.193 -0.7 H3084H06 Unknown -0.303 -0.533 0.684 -0.394 H3087E06 Human ADP-ribosylation factor binding protein GGA1 XM_038708.1 -0.781 -0.501 0.354 -0.108 H3088C07 Human chr 11 clone RP11-582N4 XM_061754.1 -0.417 -0.483 0.666 -0.384 H3090G02 Rat unr with unknown function X52311.1 -0.44 -0.548 0.435 -0.561 H3090H02 Mouse ubiquitin conjugating enzyme 2e (Ubc2e) NM_031237.1 -0.416 -0.39 0.62 -0.537 H3091C01 Unknown -0.544 -0.377 0.196 -0.722 H3092D03 Unknown -0.682 -0.573 0.143 -0.429 H3095E10 Mouse claudin 3 (Cldn3) NM_009902.1 -0.792 -0.5 0.262 -0.231 H3096A12 Mouse MHC class I heavy chain precursor (H-2D(b)) U47325.1 -0.705 -0.192 0.594 -0.335 H3097F01 Human endoplasmic reticulum glycoprotein (GP36B) NM_006816.1 -0.352 -0.476 0.756 -0.276 H3097F06 Rat acyl-CoA synthetase 5 AB012933.1 -0.541 -0.212 0.637 -0.506 H3098H02 Human carbonyl reductase BC001470.1 -0.551 -0.596 0.577 -0.086 H3098H06 Mouse TATA box binding protein (TBP)-associated factor NM_020024.1 -0.422 -0.226 0.775 -0.411 H3099F02 Unknown -0.691 -0.143 0.648 -0.283 H3100D02 Human translocating chain-associating membrane protein (TRAM) AY029764.1 -0.177 -0.606 0.693 -0.346 H3101D04 Moues RAB/Rip AF057287.1 -0.652 -0.319 0.651 -0.217 H3104B07 Mouse RNA binding protein (3'-chimera?) AY030275.1 -0.677 -0.379 0.418 -0.47 H3104D08 Unknown -0.71 -0.531 0.451 -0.094 H3104E07 Human putative cDNA clone FLJ13492 fis AK023554.1 -0.717 -0.268 0.641 0.047 H3104F05 Human hypothetical protein BC000048.1 -0.754 -0.248 0.517 -0.318 H3104G03 Human cDNA LOC131750 (5'-0%, 3'-29% masked) XM_067532.1 -0.774 -0.14 0.59 -0.177 H3105G12 Unknown -0.205 -0.562 0.594 -0.536 H3106A03 Unknown -0.529 0.073 0.545 -0.645 H3106D04 Mouse Ras-GTPase-activating protein SH3-domain binding protein (G3bp) NM_013716.1 -0.321 -0.171 0.648 -0.668 H3107D03 Unknown -0.459 -0.435 0.186 -0.751 H3108C09 Rat major epididymis-specific protein E4 precursor Q28631 -0.57 -0.181 0.383 -0.702 H3108G11 Human HSPC (CD34+ hematopoietic stem/progenitor cells)-182 protein XM_001588.4 -0.472 -0.384 0.713 -0.347 H3108H04 Mouse adenylyl cyclase 9 U30602.1 -0.365 -0.228 0.48 -0.763 H3110B02 Unknown AL355176.10 -0.691 -0.038 0.571 -0.44 H3111C05 Unknown AK007560.1 -0.455 -0.388 0.578 -0.553 H3111G01 Human putative cDNA clone FLJ22222 NM_024648.1 -0.459 -0.411 0.627 -0.474 H3112E01 Mouse small nuclear ribonucleoprotein E BC008262.1 -0.501 0.103 0.643 -0.568 H3113D03 Mouse basonuclin U88064.1 -0.346 -0.052 0.602 -0.717 H3114A08 Mouse eIF-1A (eIF-1A) XM_040535.1 -0.106 -0.571 0.74 -0.338 H3114B04 Mouse radixin (Rdx) an actin barbed-end capping protein NM_009041.1 -0.389 -0.431 0.658 -0.478 H3115A03 Mouse pescadillo (zebrafish) homolog 1 BC011142.1 -0.141 -0.543 0.66 -0.498 H3115A05 Mouse phospholipase C, delta (Plcd) NM_019676.1 -0.432 -0.461 0.638 -0.438 H3115F03 Mouse stimulated by retinoic acid gene 6 (Stra6) NM_009291.1 -0.313 -0.494 0.567 -0.578 H3118F04 Unknown -0.578 0.137 0.563 -0.573 H3121D05 Mouse flightless I homolog (Fliih) NM_022009.1 -0.683 -0.218 0.653 -0.242 H3122F12 Mouse sterol-carrier protein X M91458.1 -0.655 -0.104 0.684 -0.302 H3123D01 Mouse synaptotagmin 4 (Syt4) NM_009308.1 -0.515 -0.308 0.739 -0.303 H3126D11 Human cDNA LOC128855 XM_047013.2 -0.55 0.129 0.584 -0.581 H3127B04 Unknown AK012609.1 -0.547 0.118 0.533 -0.633 H3128A06 Mouse 11 BAC RP23-270L8 AY007567.1 -0.311 -0.178 0.658 -0.661 H3128B04 Mouse bHLH liver-specific gene on mouse chr 7 (Lisch7) U49507.1 -0.616 -0.468 0.602 -0.193 H3128F12 Unknown -0.492 -0.649 0.551 -0.176 H3129A01 Mouse acetaldehyde dehydrogenase S75713.1 -0.63 -0.465 0.561 -0.266 H3129A02 Human TGFB-induced factor 2 (TALE family homeobox) AF055012.1 -0.772 -0.134 0.599 -0.158 H3129A03 Human KIAA0261 XM_042946.1 -0.328 -0.416 0.608 -0.59 H3130B02 Mouse eukaryotic translation initiation factor 4E (Eif4e) NM_007917.1 -0.559 -0.531 0.635 0.017 H3130C02 Mouse calcineurin inhibitor AF263240.1 -0.332 -0.294 0.661 -0.604 H3130C03 Mouse hypothetical protein MGC7014 NM_030256.1 -0.343 -0.413 0.568 -0.622 H3130D12 Mouse MGC-24/ cd164 antigen BC005414.1 -0.425 -0.329 0.739 -0.404 H3130F02 Mouse StAR-related protein p3-15E/p3-16E /3'-repeat (66% masked) AY007809.1 -0.659 -0.397 0.636 0.047 H3130H04 Human KIAA1287 XM_040177.4 -0.497 -0.334 0.708 -0.373 H3131H02 Mouse protein kinase C and casein kinase substrate in neurons 2 (Pacsin2) NM_011862.1 -0.222 -0.697 0.589 -0.341 H3133A06 Mouse glutathione S-transferase mu 1 (Gstm1) NM_010358.1 -0.328 -0.569 0.739 -0.145 H3133B02 Human putative cDNA clone FLJ22347 XM_043270.1 -0.687 -0.225 0.549 -0.416 H3133D04 Rat 24-kDa subunit of mitochondrial NADH dehydrogenase M22756.1 -0.31 -0.472 0.679 -0.468 H3134G04 Rat vasa like gene RVLG -0.427 -0.202 0.791 -0.387 H3135D12 Mouse septin 9 (Sept9)/ Sint1 NM_017380.1 -0.507 -0.466 0.565 -0.452 H3136B09 Mouse branched chain ketoacid dehydrogenase E1 alpha (Bckdha) BC003787.1 -0.575 -0.353 0.663 -0.32 H3136D08 Human GDP-mannose pyrophosphorylase A XM_018159.2 -0.607 -0.548 0.541 -0.194 H3138D05 Unknown -0.47 -0.425 0.694 -0.341 H3138D07 Mouse voltage-dependent anion channel 2 (Vdac2) NM_011695.1 -0.191 -0.566 0.682 -0.42 H3138D08 Mouse paraoxonase 3 (Pon3) NM_008897.1 -0.438 -0.624 0.643 -0.057 H3141C07 Mouse cysteine and histidine-rich protein NM_019396.1 -0.273 -0.569 0.689 -0.355 H3143D02 Mouse smoothened AF089721.1 -0.675 -0.402 0.617 0.025 H3144F08 Mouse hemochromatosis (HFE) ortholog of the human HLA-H AF007558.1 -0.524 -0.354 0.602 -0.486 H3146B06 Unknown -0.569 -0.518 0.636 0.033 H3146B08 Unknown -0.68 -0.426 0.587 0.091 H3146D06 Human NYD-SP6 AY014283.2 -0.637 -0.426 0.638 -0.06 H3146F06 Mouse hybrid receptor gp250 precursor AF031816.1 -0.746 -0.209 0.618 -0.122 H3146H11 Mouse gene trap ROSA 26 antisense NM_008188.1 -0.724 -0.498 0.473 -0.058 H3148B08 Unknown AK014671.1 -0.645 -0.465 0.604 -0.043 H3149B10 Mouse protein kinase C, zeta (Pkcz) NM_008860.1 -0.702 -0.252 0.626 -0.224 H3149F02 Unknown -0.574 -0.053 0.678 -0.453 H3152D08 Human unknown mRNA AY027807.1 -0.49 -0.171 0.442 -0.731 H3153C01 Human putative cDNA clone 475B7 AL050306.5 -0.38 -0.194 0.664 -0.613 H3155F04 Murine genomic DNA AF059580.1 -0.688 -0.342 0.627 0.119 Cluster #2 H3003B03 Human cyclophilin 40 NM_005038.1 0.229 -0.112 0.197 -0.946 H3005F03 Mouse prealbumin D89076.1 0.163 -0.248 0.043 -0.953 H3007D07 Unknown 0.038 -0.023 0.108 -0.993 H3007D11 Unknown 0.145 -0.292 0.12 -0.937 H3007E07 Human KIAA1557 0.235 -0.148 0.065 -0.958 H3007F07 Human chr15 open reading frame 4 0.053 -0.026 0.096 -0.993 H3008D06 Unknown 0.191 -0.06 0.317 -0.926 H3008F05 Human histidyl-tRNA synthetase homolog U18937.1 0.193 -0.213 0.314 -0.904 H3008H07 Human hypothetical protein FLJ12707 XM_041121.1 0.3 -0.328 0.273 -0.852 H3009F03 Mouse H2A histone family member Z (H2afz) NM_016750.1 0.155 -0.094 0.202 -0.962 H3009F11 Human KIAA1398 AB037819.2 0.032 -0.03 0.108 -0.993 H3012C05 Mouse craniofacial development protein 1 (Cfdp) BC005589.1 0.193 -0.237 0.314 -0.898 H3012D07 Mouse Ap2m1, medium chains of clathrin-associated adaptor protein complex AF001923.1 0.316 0.072 0.059 -0.943 H3012F07 Unknown 0.049 -0.132 0.13 -0.981 H3012G05 Mouse clone MGC:18655 BC012213.1 0.181 -0.136 0.162 -0.96 H3013B07 Human clone IMAGE:4424947 XM_040048.3 0.051 -0.188 0.126 -0.972 H3013D07 Mouse H3 histone family 3B (H3f3b) NM_008211.1 0.239 -0.281 0.231 -0.9 H3013D08 Mouse H3 histone family 3B (H3f3b) NM_008211.1 0.185 -0.202 0.269 -0.922 H3013F07 Human ubiquinol-cytochrome c reductase hinge protein XM_027988.1 0.371 -0.303 0.265 -0.836 H3013F09 Unknown 0.103 -0.116 0.197 -0.967 H3013G07 Mouse Testis Brain RNA-binding protein (Tbrbp) AF234179.1 0.358 -0.104 -0.077 -0.924 H3013H07 Human GK004 AF284752.1 0.119 -0.249 0.091 -0.956 H3013H12 Mouse clone MGC:7094 BC014695.1 0.05 -0.015 0.087 -0.994 H3014A06 Rat protein associating with small stress
Load more

Recommended publications
  • In Vivo Analysis of Exosome Trafficking and Function in Drosophila Melanogaster
    In vivo analysis of exosome trafficking and function in Drosophila melanogaster Senior thesis Presented to The Faculty of the School of Arts and Sciences Brandeis University Undergraduate Program in Biology Professor Avital A. Rodal, PhD, Advisor In partial fulfillment of the requirements for the degree of Bachelor of Science by Anna Yeh May 11, 2016 Copyright by Anna Yeh Committee members Name: _____________________________ Signature: _____________________________ Name: _____________________________ Signature: _____________________________ Name: _____________________________ Signature: _____________________________ 1 Table of Contents 1 Abstract 4 2 Introduction 5 2.1 Exosomes: function and therapeutic applications 6 2.2 Exosome cargo and targeting specificity 6 2.3 Exosomes and the endocytic process 7 2.3.1 Rab proteins play a role in exosome trafficking in the donor cell 7 2.3.2 SNARE machinery is necessary for exosomal trafficking from the donor cell 8 2.3.3 Exosome uptake by the recipient cell 9 2.4 Drosophila as an in vivo model organism to study exosome function and trafficking 10 2.4.1 Physiological function for neuronal exosomes in Drosophila 10 2.4.2 Organismal level of exosome trafficking 11 2.5 Current methods and techniques in exosome research 12 2.5.1 Biochemical approaches for exosome analysis 13 2.5.2 Genetic and molecular biology approaches for in vivo exosome research 14 Methods 16 3.1 Molecular cloning 16 3.1.1 Construction of pattB-13xLexAop2-Sun-5Myc-spGFP11 16 3.1.2 Construction of pUASt-attB-spGFP1-10-WPRE 16 3.1.3
    [Show full text]
  • Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
    cells Review Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications Rachel Shi, Chengheng Liao and Qing Zhang * Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; [email protected] (R.S.); [email protected] (C.L.) * Correspondence: [email protected]; Tel.: +1-214-645-4671 Abstract: Hypoxia, a common feature of solid tumors, greatly hinders the efficacy of conventional cancer treatments such as chemo-, radio-, and immunotherapy. The depletion of oxygen in proliferat- ing and advanced tumors causes an array of genetic, transcriptional, and metabolic adaptations that promote survival, metastasis, and a clinically malignant phenotype. At the nexus of these intercon- nected pathways are hypoxia-inducible factors (HIFs) which orchestrate transcriptional responses under hypoxia. The following review summarizes current literature regarding effects of hypoxia on DNA repair, metastasis, epithelial-to-mesenchymal transition, the cancer stem cell phenotype, and therapy resistance. We also discuss mechanisms and pathways, such as HIF signaling, mitochon- drial dynamics, exosomes, and the unfolded protein response, that contribute to hypoxia-induced phenotypic changes. Finally, novel therapeutics that target the hypoxic tumor microenvironment or interfere with hypoxia-induced pathways are reviewed. Keywords: hypoxia; metastasis; hypoxia-inducible factors; chemoresistance Citation: Shi, R.; Liao, C.; Zhang, Q. Hypoxia-Driven Effects in Cancer: 1. Introduction Characterization, Mechanisms, and Understanding the mechanisms by which cells sense oxygen and maintain oxygen Therapeutic Implications. Cells 2021, homeostasis is of pivotal importance for science and medicine. Only in recent decades have 10, 678. https://doi.org/10.3390/ breakthrough discoveries of mechanisms for eukaryotic oxygen sensing been made.
    [Show full text]
  • Entrez Symbols Name Termid Termdesc 117553 Uba3,Ube1c
    Entrez Symbols Name TermID TermDesc 117553 Uba3,Ube1c ubiquitin-like modifier activating enzyme 3 GO:0016881 acid-amino acid ligase activity 299002 G2e3,RGD1310263 G2/M-phase specific E3 ubiquitin ligase GO:0016881 acid-amino acid ligase activity 303614 RGD1310067,Smurf2 SMAD specific E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 308669 Herc2 hect domain and RLD 2 GO:0016881 acid-amino acid ligase activity 309331 Uhrf2 ubiquitin-like with PHD and ring finger domains 2 GO:0016881 acid-amino acid ligase activity 316395 Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 361866 Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 GO:0016881 acid-amino acid ligase activity 117029 Ccr5,Ckr5,Cmkbr5 chemokine (C-C motif) receptor 5 GO:0003779 actin binding 117538 Waspip,Wip,Wipf1 WAS/WASL interacting protein family, member 1 GO:0003779 actin binding 117557 TM30nm,Tpm3,Tpm5 tropomyosin 3, gamma GO:0003779 actin binding 24779 MGC93554,Slc4a1 solute carrier family 4 (anion exchanger), member 1 GO:0003779 actin binding 24851 Alpha-tm,Tma2,Tmsa,Tpm1 tropomyosin 1, alpha GO:0003779 actin binding 25132 Myo5b,Myr6 myosin Vb GO:0003779 actin binding 25152 Map1a,Mtap1a microtubule-associated protein 1A GO:0003779 actin binding 25230 Add3 adducin 3 (gamma) GO:0003779 actin binding 25386 AQP-2,Aqp2,MGC156502,aquaporin-2aquaporin 2 (collecting duct) GO:0003779 actin binding 25484 MYR5,Myo1e,Myr3 myosin IE GO:0003779 actin binding 25576 14-3-3e1,MGC93547,Ywhah
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Mutant IDH, (R)-2-Hydroxyglutarate, and Cancer
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer Julie-Aurore Losman1 and William G. Kaelin Jr.1,2,3 1Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA; 2Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA Mutations in metabolic enzymes, including isocitrate whether altered cellular metabolism is a cause of cancer dehydrogenase 1 (IDH1) and IDH2, in cancer strongly or merely an adaptive response of cancer cells in the face implicate altered metabolism in tumorigenesis. IDH1 of accelerated cell proliferation is still a topic of some and IDH2 catalyze the interconversion of isocitrate and debate. 2-oxoglutarate (2OG). 2OG is a TCA cycle intermediate The recent identification of cancer-associated muta- and an essential cofactor for many enzymes, including tions in three metabolic enzymes suggests that altered JmjC domain-containing histone demethylases, TET cellular metabolism can indeed be a cause of some 5-methylcytosine hydroxylases, and EglN prolyl-4-hydrox- cancers (Pollard et al. 2003; King et al. 2006; Raimundo ylases. Cancer-associated IDH mutations alter the enzymes et al. 2011). Two of these enzymes, fumarate hydratase such that they reduce 2OG to the structurally similar (FH) and succinate dehydrogenase (SDH), are bone fide metabolite (R)-2-hydroxyglutarate [(R)-2HG]. Here we tumor suppressors, and loss-of-function mutations in FH review what is known about the molecular mechanisms and SDH have been identified in various cancers, in- of transformation by mutant IDH and discuss their im- cluding renal cell carcinomas and paragangliomas.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • ARTICLE Doi:10.1038/Nature10523
    ARTICLE doi:10.1038/nature10523 Spatio-temporal transcriptome of the human brain Hyo Jung Kang1*, Yuka Imamura Kawasawa1*, Feng Cheng1*, Ying Zhu1*, Xuming Xu1*, Mingfeng Li1*, Andre´ M. M. Sousa1,2, Mihovil Pletikos1,3, Kyle A. Meyer1, Goran Sedmak1,3, Tobias Guennel4, Yurae Shin1, Matthew B. Johnson1,Zˇeljka Krsnik1, Simone Mayer1,5, Sofia Fertuzinhos1, Sheila Umlauf6, Steven N. Lisgo7, Alexander Vortmeyer8, Daniel R. Weinberger9, Shrikant Mane6, Thomas M. Hyde9,10, Anita Huttner8, Mark Reimers4, Joel E. Kleinman9 & Nenad Sˇestan1 Brain development and function depend on the precise regulation of gene expression. However, our understanding of the complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and analysis of exon-level transcriptome and associated genotyping data, representing males and females of different ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We found that 86 per cent of the genes analysed were expressed, and that 90 per cent of these were differentially regulated at the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences were detected before birth, with subsequent increases in the similarity among regional transcriptomes. The transcriptome is organized into distinct co-expression networks, and shows sex-biased gene expression and exon usage. We also profiled trajectories of genes associated with neurobiological categories and diseases, and identified associations between single nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain transcriptome and insights into the transcriptional foundations of human neurodevelopment.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Epigenetic Regulation of Endothelial-Cell-Mediated Vascular Repair Sylvain Fraineau1,2,3, Carmen G
    REVIEW ARTICLE Epigenetic regulation of endothelial-cell-mediated vascular repair Sylvain Fraineau1,2,3, Carmen G. Palii1,3, David S. Allan1 and Marjorie Brand1,2,3 1 Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Canada 2 Department of Cellular and Molecular Medicine, University of Ottawa, Canada 3 Ottawa Institute of Systems Biology, Canada Keywords Maintenance of vascular integrity is essential for the prevention of vascular DNA methylation; endothelial progenitors; disease and for recovery following cardiovascular, cerebrovascular and epigenetics; epigenetic drugs; histone peripheral vascular events including limb ischemia, heart attack and stroke. acetylation; histone methylation; non-coding Endothelial stem/progenitor cells have recently gained considerable interest RNAs; stem cell therapy; transcription factors; vascular ischemic disease due to their potential use in stem cell therapies to mediate revascularization after ischemic injury. Therefore, there is an urgent need to understand fun- Correspondence damental mechanisms regulating vascular repair in specific cell types to M. Brand, Sprott Center for Stem Cell develop new beneficial therapeutic interventions. In this review, we high- Research, Regenerative Medicine Program, light recent studies demonstrating that epigenetic mechanisms (including Ottawa Hospital Research Institute, Ottawa post-translational modifications of DNA and histones as well as non-cod- ON K1H8L6, Canada ing RNA-mediated processes) play essential roles in the regulation of endo- Fax: +1 613 739 6294 Tel: +1 613 737 7700 ext. 70336 thelial stem/progenitor cell functions through modifying chromatin E-mail: [email protected] structure. Furthermore, we discuss the potential of using small molecules that modulate the activities of epigenetic enzymes to enhance the vascular (Received 21 October 2014, revised 17 repair function of endothelial cells and offer insight on potential strategies December 2014, accepted 19 December that may accelerate clinical applications.
    [Show full text]
  • The Viral Oncoproteins Tax and HBZ Reprogram the Cellular Mrna Splicing Landscape
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.18.427104; this version posted January 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape Charlotte Vandermeulen1,2,3, Tina O’Grady3, Bartimee Galvan3, Majid Cherkaoui1, Alice Desbuleux1,2,4,5, Georges Coppin1,2,4,5, Julien Olivet1,2,4,5, Lamya Ben Ameur6, Keisuke Kataoka7, Seishi Ogawa7, Marc Thiry8, Franck Mortreux6, Michael A. Calderwood2,4,5, David E. Hill2,4,5, Johan Van Weyenbergh9, Benoit Charloteaux2,4,5,10, Marc Vidal2,4*, Franck Dequiedt3*, and Jean-Claude Twizere1,2,11* 1Laboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.2Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.3Laboratory of Gene Expression and Cancer, GIGA Institute, University of Liege, Liege, Belgium.4Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. 5Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.6Laboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, University of Lyon, Lyon, France.7Department of Pathology and Tumor Biology, Kyoto University, Japan.8Unit of Cell and Tissue Biology, GIGA Institute, University of Liege, Liege, Belgium.9Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Catholic University of Leuven, Leuven, Belgium.10Department of Human Genetics, CHU of Liege, University of Liege, Liege, Belgium.11Lead Contact. *Correspondence: [email protected]; [email protected]; [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.01.18.427104; this version posted January 18, 2021.
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]